about
Good manufacturing practices for medicinal products for human use.Lysozyme Photochemistry as a Function of Temperature. The Protective Effect of Nanoparticles on Lysozyme PhotostabilityEGF Functionalized Polymer-Coated Gold Nanoparticles Promote EGF Photostability and EGFR Internalization for Photothermal TherapyNanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.Bioproduction of gold nanoparticles for photothermal therapy.Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems.Nanoparticle strategies for the oral delivery of insulin.Nanotechnology as a promising strategy for alternative routes of insulin delivery.Drug carriers for oral delivery of peptides and proteins: accomplishments and future perspectives.Reactivity of Diterpenoid Quinones: Royleanones.An emerging integration between ionic liquids and nanotechnology: general uses and future prospects in drug delivery.Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents.Polymeric nanoparticles modified with fatty acids encapsulating betamethasone for anti-inflammatory treatment.An Overview of Pharmaceutical Excipients: Safe or Not Safe?Phytosomes as Biocompatible Carriers of Natural Drugs.Pancreatic Cancer Therapy Review: from classic therapeutic agents to modern nanotechnologies.Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment.Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment.Nanoparticulate biopolymers deliver insulin orally eliciting pharmacological response.Broad overview of engineering of functional nanosystems for skin delivery.Design of Finasteride-Loaded Nanoparticles for Potential Treatment of Alopecia.Alginate microparticles as novel carrier for oral insulin delivery.Functionalized diterpene parvifloron D-loaded hybrid nanoparticles for targeted delivery in melanoma therapy.Development and evaluation of a novel topical treatment for acne with azelaic acid-loaded nanoparticles.Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity.An industry update: what is the latest news in the therapeutic delivery field?Extraction Optimization and Structural and Thermal Characterization of the Antimicrobial Abietane 7α-Acetoxy-6β-hydroxyroyleanone.Anticancer properties of the abietane diterpene 6,7-dehydroroyleanone obtained by optimized extraction.Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challengesBioadhesive polymeric nanoparticles as strategy to improve the treatment of yeast infections in oral cavity: in-vitro and ex-vivo studiesOral Delivery of BiopharmaceuticalsDevelopment of a bioadhesive nanoformulation with Glycyrrhiza glabra L. extract against Candida albicansDevelopment of Parvifloron D-loaded Smart Nanoparticles to Target Pancreatic CancerSupercritical CO2 Extracts and Volatile Oil of Basil (Ocimum basilicum L.) Comparison with Conventional MethodsDesign of polymeric nanoparticles and its applications as drug delivery systems for acne treatmentCholine-Based Ionic Liquids: Improvement of Antimicrobial ActivityCurrent Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based SystemsComparison Study of Different Extracts of Plectranthus madagascariensis, P. neochilus and the Rare P. porcatus (Lamiaceae): Chemical Characterization, Antioxidant, Antimicrobial and Cytotoxic Activities.
P50
Q27687146-89EAF841-A677-4CC7-BFB3-AAF4CEB23EBAQ28551533-348D486B-AFE1-4A5B-B913-EDCD14E30484Q28553040-3F9CD997-CEFB-4275-BB5D-0E91129F3D73Q33272232-92E7DCA7-D48B-4255-ACA3-64B4B74CF99DQ35989149-F831DB1A-8E9F-434A-A92B-C179AD4A1643Q36733054-B82D557A-E547-47A9-A7FB-8186E0C30766Q36733067-06F5EE1C-0FD6-4ABA-B20A-F38BEEA58097Q37039026-7AE6E8BC-C8D1-4500-913D-6BAEC319B463Q37997221-0391608C-C3D9-46EA-B662-F49728BE141DQ38076188-88E3C5DE-C768-4B4D-B5BE-F1216A0ABE98Q38665507-DB724C48-46C7-44D7-A8D6-9DAC20015577Q38681052-AEC696BE-B44B-4FF4-A7DE-C04840C3562FQ38814420-23A04111-8257-4E04-AAB0-25BA456EA6AAQ38848160-4BA02FA7-5AD1-4DE1-8806-F56E49634FE8Q38854671-2299F0F2-07F9-437B-86FC-A48B0887E8B6Q38996565-28AF660B-BFA7-415D-BD4E-07FAB4CBB1BBQ39117305-99887D67-A5FF-4AF8-A8CB-A5826311242EQ39205555-D71CC048-74CD-4F3D-8CE4-7BB2C7EBEDA7Q41557477-AF42E916-BB2F-494B-B8A7-421D3ED648FAQ44328880-0EEB6476-3797-45C9-8CCC-7527B7D3C0C8Q46668119-2503C664-BACA-48CB-9600-407F05D31E36Q47855670-68A5A379-46D0-4ADA-8620-B351132D6504Q50540368-5870C44E-9E3B-490D-8306-B19CEABFC759Q51128409-AFAAE285-38D8-485D-8B9B-7713ADC40CE4Q51238627-DB865720-C4ED-406F-8EE8-1AD056F30DC8Q51811824-0548DD58-9606-40BE-B32A-016F3371D7B8Q52571178-B2ECF6AC-5B6B-45A1-877C-DE9EAB315B6BQ52571826-759604CC-B137-4F92-9FC9-5B8E45F6A348Q52679695-6D542695-531D-41DE-9CD6-991E7F3303F7Q53684056-5E363909-2263-4953-978B-A14B86BF0DC2Q57062827-84B94D01-909C-4E98-89BA-E5A4BE609633Q57570623-DF4A818B-E8DB-4A55-A425-076581FFA719Q57570808-BA6D5DAE-B3D5-41F0-ADBD-64AD424C2557Q58604695-552D97B7-078F-471C-9413-6BAA3FCF3AF4Q58613220-AE99E139-40C8-40EC-88B5-BBDC8B2184E6Q58838040-2AF9E234-822E-4C87-9BDB-AEA326682473Q59347534-7B2BE960-C255-49CC-9067-EC6971CFC9C8Q60545208-DD14AA2E-9244-4601-BDE4-6583EA782881Q61803672-4E3BCFEF-C2A4-46C9-9112-308504C64FECQ64885409-EBEA6650-0596-471A-A412-20B901E52A8E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Catarina Pinto Reis
@ast
Catarina Pinto Reis
@en
Catarina Pinto Reis
@es
Catarina Pinto Reis
@nl
Catarina Pinto Reis
@sl
type
label
Catarina Pinto Reis
@ast
Catarina Pinto Reis
@en
Catarina Pinto Reis
@es
Catarina Pinto Reis
@nl
Catarina Pinto Reis
@sl
prefLabel
Catarina Pinto Reis
@ast
Catarina Pinto Reis
@en
Catarina Pinto Reis
@es
Catarina Pinto Reis
@nl
Catarina Pinto Reis
@sl
P106
P1153
14027161300
57200828259
P21
P31
P496
0000-0002-1046-4031